Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed Al-Falah

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 22, 2022
A review of the molecular epidemiology of Cryptosporidium spp. and Giardia duodenalis in the Middle East and North Africa (MENA) regionNawal Hijjawi, Alizera Zahedi, Mohammed Al-Falah, et al.
Retinal Cases & Brief Reports|November 30, 2020
ATYPICAL PROLIFERATIVE RETINOPATHY AS THE PRESENTING FEATURE OF CHRONIC MYELOID LEUKEMIA IN A PATIENT WITH DIABETES MELLITUSMohammed Al Falah, Brian G Ballios, Shanna C Yeung, et al.
Acta Ophthalmologica|April 13, 2021
A prospective randomized clinical trial comparing nepafenac, intravitreal triamcinolone and no adjuvant therapy for epiretinal membraneEfrem D Mandelcorn, Mohammed Al-Falah, Lei Di Zhao, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 22, 2022
A review of the molecular epidemiology of Cryptosporidium spp. and Giardia duodenalis in the Middle East and North Africa (MENA) regionNawal Hijjawi, Alizera Zahedi, Mohammed Al-Falah, et al.
Retinal Cases & Brief Reports|November 30, 2020
ATYPICAL PROLIFERATIVE RETINOPATHY AS THE PRESENTING FEATURE OF CHRONIC MYELOID LEUKEMIA IN A PATIENT WITH DIABETES MELLITUSMohammed Al Falah, Brian G Ballios, Shanna C Yeung, et al.
Acta Ophthalmologica|April 13, 2021
A prospective randomized clinical trial comparing nepafenac, intravitreal triamcinolone and no adjuvant therapy for epiretinal membraneEfrem D Mandelcorn, Mohammed Al-Falah, Lei Di Zhao, et al.
Pageof 1